Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels
- 1 February 1991
- journal article
- Published by Elsevier in Kidney International
- Vol. 39 (2) , 259-265
- https://doi.org/10.1038/ki.1991.31
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietinKidney International, 1989
- BLOOD PRESSURE AND ERYTHROPOIETINThe Lancet, 1988
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- RECOMBINANT ERYTHROPOIETIN AND BLOOD PRESSUREThe Lancet, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Cloning and expression of the human erythropoietin gene.Proceedings of the National Academy of Sciences, 1985
- Isolation and characterization of genomic and cDNA clones of human erythropoietinNature, 1985
- Hemodynamics of Uremic AnemiaCirculation, 1971
- The kidney and erythropoiesisThe American Journal of Medicine, 1968